D Macaro
YOU?
Author Swipe
A randomized, double-blinded, phase 2 trial of EDP1815, an oral immunomodulatory preparation of Prevotella histicola, in adults with mild-to-moderate plaque psoriasis Open
Background Psoriasis is a chronic inflammatory skin disease. EDP1815 is an oral, gut-restricted preparation of non-live Prevotella histicola , the first of a new immunomodulatory therapeutic class targeting the small intestine to generate …